Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells

Published:2014-03 Issue: Volume:181 Page:61-71
ISSN:0168-1702
Container-title:Virus Research
language:en
Short-container-title:Virus Research

Author:

Fang Lin,Cheng Qian,Li Wang,Liu Junjie,Li Liantao,Xu Kai,Zheng Junnian

Funder

National Natural Science Foundation of China

Science Foundation of China Postdoctoral

Science and Technology Department of Jiangsu Province

Science and Technology Department of Xuzhou

Science Foundation of Xuzhou Medical College

Publisher

Elsevier BV

Subject

Cancer Research,Infectious Diseases,Virology

Reference27 articles.

1. Recent patents on anti-telomerase cancer therapy;Agrawal;Recent Pat. Anticancer Drug Discov.,2012

2. Molecular grading of ductal carcinoma in situ of the breast;Balleine;Clin. Cancer Res.,2008

3. Triple-targeted oncolytic adenoviruses featuring the cox2 promoter, E1A transcomplementation, and serotype chimerism for enhanced selectivity for ovarian cancer cells;Bauerschmitz;Mol. Ther.,2006

4. Comparison of the prognostic value of genomic grade index Ki67 expression and mitotic activity index in early node-positive breast cancer patients;Bertucci;Ann. Oncol.,2013

5. The use of oncolytic adenovirus for the treatment of cancer;Cascallo;Methods Find. Exp. Clin. Pharmacol.,2010

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Tumor-Associated Antigen: A Promising CAR-T Therapeutic Strategy for Glioblastoma Treatment;Frontiers in Pharmacology;2021-06-24

2. Strategies to Develop Potent Oncolytic Viruses and Enhance Their Therapeutic Efficacy;JCO Precision Oncology;2021-04

3. FAM72, Glioblastoma Multiforme (GBM) and Beyond;Cancers;2021-03-01

4. Efficacy of a novel double-controlled oncolytic adenovirus driven by the Ki67 core promoter and armed with IL-15 against glioblastoma cells;Cell & Bioscience;2020-10-27

5. Recombinant Oncolytic Vaccinia Viruses Expressing Human β-Defensin 2 Enhance Anti-tumor Immunity;Molecular Therapy - Oncolytics;2019-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3